AVADEL PHARMACEUTICALS PLC AVDL Income Statement

Avadel pharmaceuticals plc (AVDL)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Jun'11	Mar'11
Revenues:
Total revenues
55,021	59,215	69,140	74,737	86,413	103,269	122,024	149,303	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License revenue
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	163,626	-	148,505	164,478	174,915	172,288	129,628	87,062	40,959	12,193	5,557	3,310	3,006	1,153	-132	-569	-711	560	0	0	0	0	0
License revenue
-	-	-	-	-	-	-	-	-	-	-	-	2,911	-	3,024	2,277	1,584	721	-316	365	2,184	2,782	2,009	2,520	2,351	3,026	4,965	5,483	5,887	6,724	0	0	0	0	0
Other revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	174	-92	138	250	0	0	0	0	0
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	166,537	-	151,529	166,755	176,499	173,009	127,692	87,407	43,123	14,975	3,839	2,394	3,617	4,179	5,007	4,822	5,314	7,534	0	0	0	0	0
Operating expenses:
Cost of products
11,316	12,125	14,003	14,300	14,190	17,516	17,272	17,942	18,991	16,301	14,844	13,898	13,244	13,248	13,594	12,837	11,686	11,410	8,663	8,489	6,240	3,383	-259	-436	340	562	49	-187	77	400	0	0	0	0	0
Research and development expenses
31,118	32,917	31,246	35,109	36,707	39,329	44,568	41,261	36,163	33,418	35,569	35,617	36,429	34,611	26,296	25,374	24,974	25,608	23,173	22,980	19,376	17,298	8,025	7,677	11,381	15,966	17,118	16,684	17,102	14,558	0	0	0	0	0
Selling, general and administrative expenses
27,650	30,183	45,720	65,233	86,318	100,359	100,215	86,949	71,535	58,860	46,492	47,669	46,530	44,179	40,299	32,127	26,710	21,712	18,916	18,453	16,645	15,698	16,780	15,600	14,241	13,216	11,072	11,254	11,461	14,153	0	0	0	0	0
Fair value remeasurement of acquisition liabilities, with related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	31,582	30,357	0	-	0	0	-	-	-
Remeasurement of acquisition liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Intangible asset amortization
818	816	2,233	3,648	5,053	6,619	6,963	5,907	4,862	3,659	4,662	7,800	10,938	13,888	14,059	13,498	12,935	12,564	12,360	12,156	11,955	11,749	8,812	5,875	2,937	0	0	0	0	-	-	-	-	-	-
Business Combination, Acquisition Related Costs
1,189	845	-3,311	-11,053	-23,565	-22,731	-17,969	-20,760	-21,101	-31,040	-33,811	-3,057	34,071	49,285	1,910	25,844	33,946	30,957	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring costs
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on early repayment of related party acquisition-related note
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,013	3,013	3,013	3,013	0	0	0	0	-	-	-	-	-	-
Total operating expenses
77,463	83,327	161,326	176,871	186,881	208,195	150,686	130,322	110,492	83,740	70,929	105,649	143,865	155,211	96,158	109,680	110,251	102,251	167,541	129,590	102,335	108,632	66,962	55,498	71,697	57,879	53,055	52,584	25,032	17,447	0	0	0	0	0
Operating loss
-22,442	-24,112	-92,186	-102,134	-100,468	-104,926	-33,585	6,628	43,539	89,505	110,649	68,341	22,672	-4,965	55,371	57,075	66,248	70,758	-39,849	-42,183	-59,212	-93,657	-63,123	-53,104	-68,080	-53,700	-48,048	-47,762	-19,718	-9,913	0	0	0	0	0
Investment and other income, net
-126	1,069	2,155	1,582	1,215	452	419	1,188	1,369	2,136	4,240	3,753	3,379	2,758	1,145	852	772	1,236	1,257	0	0	-	0	-	728	254	0	0	0	-	0	-	-	-	-
Net interest income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Interest income net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Interest expense
12,611	12,483	12,338	12,213	12,087	10,622	7,840	5,103	2,386	1,052	1,050	1,051	1,051	963	702	438	175	0	3,026	4,512	5,591	5,747	3,295	1,822	2,758	2,602	2,028	2,015	0	-	0	0	-	-	-
Loss on deconsolidation of subsidiary
-5	-2,678	-2,840	-2,840	-2,673	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other expense - changes in fair value of contingent consideration payable
-381	-378	-29	535	1,987	1,899	515	858	1,126	2,071	2,575	-21	-4,464	-6,548	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other expense - changes in fair value of related party payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign exchange (loss) gain
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,486	1,397	-3,848	10,594	11,422	19,336	23,193	11,871	8,427	192	-133	-288	-278	-212	-23	-180	0	0	0	0	0
Other Income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	543	492	0	102	0	0	0	0	0
Loss before income taxes
-35,565	-38,582	-105,238	-115,070	-112,026	-113,197	-40,491	3,571	43,648	92,660	116,426	72,283	23,477	-9,718	56,911	52,681	56,839	77,705	-37,334	-26,636	-38,348	-90,131	-63,104	-60,626	-77,125	-57,753	-51,584	-50,460	-19,814	-9,469	0	0	0	0	0
Income tax benefit
-14,492	-5,356	-10,892	-13,817	-15,940	-17,893	-801	5,811	13,523	24,389	35,176	32,706	32,785	31,558	27,837	31,688	32,746	35,907	28,332	21,001	12,631	-644	-7,540	-8,739	-12,584	-11,244	-11,122	-9,942	-6,233	-4,729	0	0	0	0	0
Net income (loss) from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Net income from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-21,073	-33,226	-94,346	-101,253	-96,086	-95,304	-39,690	-2,240	30,125	68,271	81,250	39,577	-9,308	-41,276	29,074	20,993	24,093	41,798	-60,998	-42,969	-47,184	-85,469	-52,630	-48,953	-60,734	-42,925	-38,950	-39,006	-12,069	-3,228	0	0	0	0	0
Earnings Per Share [Abstract]
Continuing operations (in usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.95	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	-	-	-	-	-	-	-
Net income (loss) per share - basic (in dollars per share)
-0.02	-0.07	-0.24	-0.23	-0.35	-1.71	-0.43	-0.09	-0.32	-0.18	0.54	0.70	0.63	0.11	-0.48	-0.48	-0.15	1.85	-0.69	-0.42	0.29	-	-0.26	-	-0.94	0.20	-0.25	-1.29	-0.35	0.37	-0.26	-0.24	0.00	-0.14	-0.20
Continuing operations (in usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.95	-	-	-	-	-	-	-	-	-	-
Discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	-	-	-	-	-	-	-
Net income (loss) per share - diluted (in dollars per share)
-0.02	-0.07	-0.24	-0.23	-0.35	-1.71	-0.43	-0.09	-0.32	-0.18	0.52	0.68	0.61	0.11	-0.48	-0.48	-0.15	1.80	-0.69	-0.42	0.27	-	-0.26	-	-0.94	0.20	-0.25	-1.29	-0.35	0.37	-0.26	-0.24	0.00	-0.14	-0.20
Weighted average number of shares outstanding
Continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.53	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02	-	-	-	-	-	-	-	-	-	-	-
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.55	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares outstanding - basic (in shares)
41,057	37,466	37,436	37,356	37,354	37,065	36,904	36,772	38,559	39,334	40,061	41,091	41,374	41,269	41,241	41,241	41,241	41,135	40,625	40,353	40,207	39,339	38,767	38,438	28,312	50,894	25,465	25	25,415	25,214	25,157	25,157	25,012	24	24,646
Weighted average number of shares outstanding - diluted (in shares)
41,057	37,466	37,436	37,356	37,354	37,065	36,904	36,772	38,559	40,424	41,339	42,487	42,810	41,269	41,241	41,241	41,241	50,619	40,625	40,353	42,879	39,339	38,767	38,438	28,312	50,894	25,465	25	25,415	25,214	25,157	25,157	25,012	24	24,646
Product sales
Total revenues
-	-	67,540	73,137	-	101,423	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License revenue
Total revenues
-	-	1,600	1,600	-	1,846	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-